ANNIE PRATT: Open Payments
NPI 1548644206 · ASHBURN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,467 in 184 payments from 17 companies in 2025. Trend: 2023 $829 · 2024 $1,855 · 2025 $3,467
Food & beverage: $3,397Education: $70
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 18 | $450 |
| ABBVIE INC. | 24 | $381 |
| Incyte Corporation | 17 | $330 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 17 | $311 |
| PFIZER INC. | 17 | $277 |
| Regeneron Healthcare Solutions, Inc. | 7 | $271 |
| Janssen Biotech, Inc. | 13 | $260 |
| Novartis Pharmaceuticals Corporation | 12 | $203 |
| E.R. Squibb & Sons, L.L.C. | 12 | $184 |
| GENZYME CORPORATION | 6 | $161 |
Products named: Bimzelx, DUPIXENT, OPZELURA, SKYRIZI, TREMFYA, CIBINQO, ILUMYA, Sotyktu.
Industry payments across VA — which companies pay providers there.
